Cargando…

Clozapine Can Be the Good Option in Resistant Mania

Bipolar mood disorder is a mental disorder with a lifetime prevalence rate of about 1% in the general population and there are still a proportion of individuals who suffer from bipolar mood disorders that are resistant to standard treatment. Reporting clozapine responsive mania that was not respondi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arafat, S. M. Yasir, Rahman, S. M. Atikur, Haque, Md. Maruful, Shah, Mohsin Ali, Algin, Sultana, Nahar, Jhunu Shamsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976188/
https://www.ncbi.nlm.nih.gov/pubmed/27525148
http://dx.doi.org/10.1155/2016/3081704
_version_ 1782446826974085120
author Arafat, S. M. Yasir
Rahman, S. M. Atikur
Haque, Md. Maruful
Shah, Mohsin Ali
Algin, Sultana
Nahar, Jhunu Shamsun
author_facet Arafat, S. M. Yasir
Rahman, S. M. Atikur
Haque, Md. Maruful
Shah, Mohsin Ali
Algin, Sultana
Nahar, Jhunu Shamsun
author_sort Arafat, S. M. Yasir
collection PubMed
description Bipolar mood disorder is a mental disorder with a lifetime prevalence rate of about 1% in the general population and there are still a proportion of individuals who suffer from bipolar mood disorders that are resistant to standard treatment. Reporting clozapine responsive mania that was not responding to two previous consecutive atypical antipsychotics and one typical antipsychotic was aimed at. A 17-year-old male manic patient was admitted into the psychiatry inpatient department and was nonresponsive to Risperidone 12 mg daily for 4 weeks, Olanzapine 30 mg daily for 3 weeks, and Haloperidol 30 mg daily for 3 weeks, along with valproate preparation 1500 mg daily. He was started on clozapine as he was nonresponsive to Lithium in previous episodes and did not consent to starting Electroconvulsive Therapy (ECT). He responded adequately to 100 mg clozapine and 1500 mg valproate preparation and remission happened within 2 weeks of starting clozapine. Clozapine can be a good option for resistant mania and further RCT based evidences will strengthen the options in treating resistant mania.
format Online
Article
Text
id pubmed-4976188
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49761882016-08-14 Clozapine Can Be the Good Option in Resistant Mania Arafat, S. M. Yasir Rahman, S. M. Atikur Haque, Md. Maruful Shah, Mohsin Ali Algin, Sultana Nahar, Jhunu Shamsun Case Rep Psychiatry Case Report Bipolar mood disorder is a mental disorder with a lifetime prevalence rate of about 1% in the general population and there are still a proportion of individuals who suffer from bipolar mood disorders that are resistant to standard treatment. Reporting clozapine responsive mania that was not responding to two previous consecutive atypical antipsychotics and one typical antipsychotic was aimed at. A 17-year-old male manic patient was admitted into the psychiatry inpatient department and was nonresponsive to Risperidone 12 mg daily for 4 weeks, Olanzapine 30 mg daily for 3 weeks, and Haloperidol 30 mg daily for 3 weeks, along with valproate preparation 1500 mg daily. He was started on clozapine as he was nonresponsive to Lithium in previous episodes and did not consent to starting Electroconvulsive Therapy (ECT). He responded adequately to 100 mg clozapine and 1500 mg valproate preparation and remission happened within 2 weeks of starting clozapine. Clozapine can be a good option for resistant mania and further RCT based evidences will strengthen the options in treating resistant mania. Hindawi Publishing Corporation 2016 2016-07-25 /pmc/articles/PMC4976188/ /pubmed/27525148 http://dx.doi.org/10.1155/2016/3081704 Text en Copyright © 2016 S. M. Yasir Arafat et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Arafat, S. M. Yasir
Rahman, S. M. Atikur
Haque, Md. Maruful
Shah, Mohsin Ali
Algin, Sultana
Nahar, Jhunu Shamsun
Clozapine Can Be the Good Option in Resistant Mania
title Clozapine Can Be the Good Option in Resistant Mania
title_full Clozapine Can Be the Good Option in Resistant Mania
title_fullStr Clozapine Can Be the Good Option in Resistant Mania
title_full_unstemmed Clozapine Can Be the Good Option in Resistant Mania
title_short Clozapine Can Be the Good Option in Resistant Mania
title_sort clozapine can be the good option in resistant mania
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976188/
https://www.ncbi.nlm.nih.gov/pubmed/27525148
http://dx.doi.org/10.1155/2016/3081704
work_keys_str_mv AT arafatsmyasir clozapinecanbethegoodoptioninresistantmania
AT rahmansmatikur clozapinecanbethegoodoptioninresistantmania
AT haquemdmaruful clozapinecanbethegoodoptioninresistantmania
AT shahmohsinali clozapinecanbethegoodoptioninresistantmania
AT alginsultana clozapinecanbethegoodoptioninresistantmania
AT naharjhunushamsun clozapinecanbethegoodoptioninresistantmania